Bright Rock Capital Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.02M Hold
15,500
0.61% 48
2026
Q1
$3.48M Hold
15,500
0.69% 50
2025
Q4
$3.73M Hold
15,500
0.73% 48
2025
Q3
$4.24M Hold
15,500
0.83% 45
2025
Q2
$4M Hold
15,500
0.81% 45
2025
Q1
$3.47M Hold
15,500
0.73% 46
2024
Q4
$3.54M Hold
15,500
0.76% 42
2024
Q3
$3.78M Hold
15,500
0.76% 44
2024
Q2
$2.97M Hold
15,500
0.63% 53
2024
Q1
$3.07M Hold
15,500
0.64% 53
2023
Q4
$2.67M Hold
15,500
0.6% 53
2023
Q3
$2.29M Hold
15,500
0.56% 56
2023
Q2
$3.39M Hold
15,500
0.79% 42
2023
Q1
$3.39M Hold
15,500
0.85% 38
2022
Q4
$3.23M Hold
15,500
0.84% 40
2022
Q3
$3.38M Hold
15,500
0.95% 40
2022
Q2
$3.25M Hold
15,500
0.88% 43
2022
Q1
$3.76M Hold
15,500
0.89% 42
2021
Q4
$4.04M Hold
15,500
0.92% 43
2021
Q3
$4.08M Hold
15,500
1.02% 41
2021
Q2
$3.82M Hold
15,500
0.92% 44
2021
Q1
$3.01M Hold
15,500
0.77% 47
2020
Q4
$3.29M Hold
15,500
0.9% 42
2020
Q3
$2.66M Sell
15,500
-1,500
-9% -$277K 0.79% 48
2020
Q2
$3.26M Hold
17,000
1.02% 42
2020
Q1
$2.5M Sell
17,000
-3,000
-15% -$478K 0.91% 45
2019
Q4
$3.1M Hold
20,000
0.91% 41
2019
Q3
$2.61M Hold
20,000
0.82% 46
2019
Q2
$2.44M Hold
20,000
0.78% 44
2019
Q1
$2.08M Hold
20,000
0.7% 49
2018
Q4
$2.28M Hold
20,000
0.86% 45
2018
Q3
$2.31M Hold
20,000
0.75% 45
2018
Q2
$2.07M Hold
20,000
0.71% 46
2018
Q1
$1.97M Hold
20,000
0.68% 47
2017
Q4
$1.69M Hold
20,000
0.46% 69
2017
Q3
$1.54M Hold
20,000
0.45% 68
2017
Q2
$1.56M Hold
20,000
0.46% 63
2017
Q1
$1.44M Hold
20,000
0.43% 71
2016
Q4
$1.24M Hold
20,000
0.38% 77
2016
Q3
$1.3M Hold
20,000
0.41% 72
2016
Q2
$1.26M Hold
20,000
0.41% 66
2016
Q1
$1.16M Hold
20,000
0.39% 76
2015
Q4
$1.07M Sell
20,000
-13,000
-39% -$733K 0.4% 77
2015
Q3
$1.68M Hold
33,000
0.67% 53
2015
Q2
$1.86M Buy
33,000
+10,000
+43% +$631K 0.69% 49
2015
Q1
$1.65M Sell
23,000
-7,000
-23% -$455K 0.62% 56
2014
Q4
$1.68M Hold
30,000
0.66% 52
2014
Q3
$1.48M Sell
30,000
-4,000
-12% -$204K 0.63% 52
2014
Q2
$1.72M Hold
34,000
0.81% 39
2014
Q1
$1.52M Hold
34,000
0.77% 43
2013
Q4
$1.6M Buy
34,000
+3,100
+10% +$157K 0.84% 42
2013
Q3
$1.63M Hold
30,900
0.92% 39
2013
Q2
$1.4M Buy
+30,900
New +$1.47M 0.86% 42

Other funds holding RMD

Bright Rock Capital Management's RMD Position: Q2 2026 in Review

Bright Rock Capital Management held its ResMed (RMD) position steady in Q2 2026 at 15,500 shares worth $3.02M. The position accounts for 0.61% of the portfolio, ranked #48.

Bright Rock Capital Management first reported a position in RMD in Q2 2013 and has held it in 53 quarters since. The position peaked at $4.24M in Q3 2025. 139 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Bright Rock Capital Management held 15,500 shares of ResMed worth $3.02M as of Q2 2026.
  • Bright Rock Capital Management left its ResMed share count unchanged in Q2 2026.
  • ResMed made up 0.61% of Bright Rock Capital Management's portfolio in Q2 2026, its #48 holding.
  • Bright Rock Capital Management first reported a position in ResMed in Q2 2013 and has held it in 53 quarters since.
  • Bright Rock Capital Management's ResMed position peaked at $4.24M in Q3 2025.
  • 139 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Bright Rock Capital Management's 13F filing for Q2 2026, filed 8 Jul 2026.